Design of a randomized controlled trial of smoking cessation medications for alcohol reduction among HIV-positive heavy drinkers and daily smokers in St. Petersburg, Russia

BACKGROUND: HIV, heavy drinking, and smoking are all pro-inflammatory and increase risk for coronary heart disease (CHD). Interventions that reduce alcohol use, smoking, or both in HIV-positive people could lower inflammation, CHD and death risk. Varenicline and cytisine are proven therapies for smo...

Descripción completa

Detalles Bibliográficos
Autores principales: Tindle, Hilary A., Freiberg, Matthew S., Gnatienko, Natalia, Blokhina, Elena, Cheng, Debbie M., Yaroslavtseva, Tatiana, Bendiks, Sally, Winter, Michael, Krupitsky, Evgeny, Samet, Jeffrey H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889999/
https://www.ncbi.nlm.nih.gov/pubmed/33659761
http://dx.doi.org/10.1016/j.conctc.2020.100625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889999/
https://www.ncbi.nlm.nih.gov/pubmed/33659761
http://dx.doi.org/10.1016/j.conctc.2020.100625

Ejemplares similares